Neoadjuvant Chemoimmunotherapy: Clinical Trials

1 trial for Neoadjuvant Chemoimmunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Neoadjuvant Chemoimmunotherapy: new trials by email Literature Review of Neoadjuvant Chemoimmunotherapy trials Research Report on Neoadjuvant Chemoimmunotherapy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability - Pleural Epithelioid Mesothelioma, Mesothelioma; Pleura
Phase 1 / Phase 2RecruitingUniversity Hospital, Antwerp372025-07-222025-08-13

Narrower conditions

Mesothelioma, Malignant (1)

Broader conditions

Adenoma (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Mesothelioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Mesothelial (1)  ·  Pleural Neoplasms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Cerebral Decortication (1)

Sponsors

University Hospital, Antwerp (1)

Countries

Belgium (1)

NIH funding

2023 (1)